Expression of CXC-motif-chemokine 12 and the Receptor C-X-C Receptor 4 in Glioma and Theeffect on Peritumoral Brain Edema

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 Feb 14

PMID 29434965

Citations 2

Authors

Wenlong Tang

Yupeng Chen

Xingfu Wang

Yao Chen

Jiandong Zhang

Zhixiong Lin

Affiliations

Soon will be listed here.

Abstract

The present study aimed to evaluate the association between CXC-motif-chemokine 12 (CXCL12)/C-X-C receptor 4 (CXCR4) expression and peritumoral brain edema (PTBE) in glioma patients. Immunohistochemical techniques were used to detect the expression of CXCR4 and CXCL12 in 58 glioma tissues. Magnetic resonance imaging was used to evaluate the extent and type of brain edema in preoperative glioma patients. The association between edema and CXCL12/CXCR4 expression was examined by χ analysis. The prognostic significance of CXCL12 or CXCR4 was determined by log-rank tests and Cox's proportional hazards model. Expression of CXCL12 and CXCR4 was observed in vascular endothelial cells and tumor cells. The degree (P0.033) and morphology (P0.033) of PTBE were significantly associated with the level of CXCL12 expression in vascular endothelial cells. The degree (P0.001) and morphology (P0.001) of PTBE were associated with the level of CXCR4 expression in tumor cells. CXCR4-positive vascular endothelial cells were significantly associated only with the degree of edema (P0.030). Therefore, the present study indicated that levels of CXCL12 expression in vascular endothelial cells and CXCR4 expression in tumor cells are associated with PTBE.

Citing Articles

The peritumor microenvironment: physics and immunity.

Zhang S, Regan K, Najera J, Grinstaff M, Datta M, Nia H Trends Cancer. 2023; 9(8):609-623.

PMID: 37156677 PMC: 10523902. DOI: 10.1016/j.trecan.2023.04.004.

Inflammation and behavioral symptoms in preoperational glioma patients: Is depression, anxiety, and cognitive impairment related to markers of systemic inflammation?.

Song L, Quan X, Su L, Wang K, Wang H, Wu L Brain Behav. 2020; 10(9):e01771.

PMID: 32790154 PMC: 7507433. DOI: 10.1002/brb3.1771.

References

Hong X, Jiang F, Kalkanis S, Zhang Z, Zhang X, deCarvalho A . SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 2005; 236(1):39-45. DOI: 10.1016/j.canlet.2005.05.011. View

Stevenson C, Ehtesham M, McMillan K, Valadez J, Edgeworth M, Price R . CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery. 2008; 63(3):560-9. PMC: 2602832. DOI: 10.1227/01.NEU.0000324896.26088.EF. View

Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y . The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998; 393(6685):591-4. DOI: 10.1038/31261. View

Ehtesham M, Winston J, Kabos P, Thompson R . CXCR4 expression mediates glioma cell invasiveness. Oncogene. 2006; 25(19):2801-6. DOI: 10.1038/sj.onc.1209302. View

Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti J . Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 2003; 63(8):1969-74. View

Bian X, Yang S, Chen J, Ping Y, Zhou X, Wang Q . Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival. Neurosurgery. 2007; 61(3):570-8. DOI: 10.1227/01.NEU.0000290905.53685.A2. View

Zhou Y, Larsen P, Hao C, Yong V . CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002; 277(51):49481-7. DOI: 10.1074/jbc.M206222200. View

Engelhorn T, Savaskan N, Schwarz M, Kreutzer J, Meyer E, Hahnen E . Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci. 2009; 100(10):1856-62. PMC: 11159753. DOI: 10.1111/j.1349-7006.2009.01259.x. View

Wu B, Chien E, Mol C, Fenalti G, Liu W, Katritch V . Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science. 2010; 330(6007):1066-71. PMC: 3074590. DOI: 10.1126/science.1194396. View

10.

Lu D, Tang C, Yeh W, Wong K, Lin C, Chen Y . SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol. 2009; 613(1-3):146-54. DOI: 10.1016/j.ejphar.2009.03.001. View

11.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

12.

Yoshie O, Imai T, Nomiyama H . Novel lymphocyte-specific CC chemokines and their receptors. J Leukoc Biol. 1997; 62(5):634-44. DOI: 10.1002/jlb.62.5.634. View

13.

Lv S, Sun B, Zhong X, Dai C, Wang W, Ma X . The Clinical Implications of Chemokine Receptor CXCR4 in Grade and Prognosis of Glioma Patients: A Meta-Analysis. Mol Neurobiol. 2014; 52(1):555-61. DOI: 10.1007/s12035-014-8894-3. View

14.

Soda Y, Myskiw C, Rommel A, Verma I . Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl). 2013; 91(4):439-48. PMC: 3665343. DOI: 10.1007/s00109-013-1019-z. View

15.

Lu S, Ahn D, Johnson G, Law M, Zagzag D, Grossman R . Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology. 2004; 232(1):221-8. DOI: 10.1148/radiol.2321030653. View

16.

Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y . Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures. Am J Pathol. 2008; 173(2):545-60. PMC: 2475791. DOI: 10.2353/ajpath.2008.071197. View

17.

Furusato B, Mohamed A, Uhlen M, Rhim J . CXCR4 and cancer. Pathol Int. 2010; 60(7):497-505. DOI: 10.1111/j.1440-1827.2010.02548.x. View

18.

Schoenegger K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D . Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?. Eur J Neurol. 2009; 16(7):874-8. DOI: 10.1111/j.1468-1331.2009.02613.x. View

19.

Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H . Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res. 2005; 65(13):5864-71. DOI: 10.1158/0008-5472.CAN-04-3833. View

20.

Lin Z . Glioma-related edema: new insight into molecular mechanisms and their clinical implications. Chin J Cancer. 2012; 32(1):49-52. PMC: 3845586. DOI: 10.5732/cjc.012.10242. View